EX-FILING FEES 4 d295777dexfilingfees.htm EX-FILING FEES EX-FILING FEES

Exhibit 107

Calculation of Filing Fee Tables

Form S-8

(Form Type)

Terns Pharmaceuticals, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

 

     

Security

Type

  

Security

Class

Title

   Fee
Calculation
Rule
  Amount
Registered (1)
  Proposed
Maximum
Offering
Price Per
Share (2)
     Maximum
Aggregate
Offering Price
    

Fee

Rate

     Amount of
Registration
Fee
 
                 

Fees to Be Paid

   Equity    Common Stock,
$0.0001 par value
per share
   457(c)

and
457(h)

  1,516,155 (3)     $3.38        $5,124,603.90       
$92.70 per
$1,000,000
 
 
     $476  
         

Fees Previously Paid

                                       
         
     Total Offering Amounts              $5,124,603.90                 $476  
         
     Total Fees Previously Paid                                —    
         
     Total Fee Offsets                                —    
         
     Net Fee Due                                $476  

 

(1)

Pursuant to Rule 416(a) of the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of the Registrant’s common stock that becomes issuable under the 2021 Incentive Award Plan (the “2021 Plan”) and the 2021 Employee Stock Purchase Plan (“ESPP”) by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without the receipt of consideration that increases the number of the Registrant’s outstanding shares of common stock.

(2)

Pursuant to 457(c) and 457(h) under the Securities Act, the proposed maximum offering price per share is estimated solely for the purpose of calculating the registration fee and is based upon the average of the high and low prices of the Registrant’s common stock as reported on the Nasdaq Global Select Market on March 1, 2022, which date is within five business days prior to filing this Registration Statement.

(3)

Consists of (i) 1,263,463 additional shares of the Registrant’s common stock that became available for issuance on January 1, 2022 under the 2021 Plan, by operation of an automatic annual increase provision therein, and (ii) 252,692 additional shares of the Registrant’s common stock that became available for issuance on January 1, 2022 under the ESPP, by operation of an automatic annual increase provision therein.